Stay updated with breaking news from Mark Haigney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(TNS) Deliberation over a proposal to invest state money in clinical research of a psychedelic drug as a potential treatment for opioid addiction is intensifying.
“It does have a certain attractiveness to think if you could give a single dose of a drug, that could give a lifetime cure,” said Dr. Mark Haigney, but, “My opinion is ibogaine is not safe.”
In a session focused on challenges of getting the psychedelic drug ibogaine approved by the Food and Drug Administration for treating addiction with help of the state’s opioid settlement funds,
In a session focused on challenges of getting the psychedelic drug ibogaine approved by the Food and Drug Administration for treating addiction with help of the state’s opioid settlement funds,